Literature DB >> 15932903

Practical FDR-based sample size calculations in microarray experiments.

Jianhua Hu1, Fei Zou, Fred A Wright.   

Abstract

MOTIVATION: Owing to the experimental cost and difficulty in obtaining biological materials, it is essential to consider appropriate sample sizes in microarray studies. With the growing use of the False Discovery Rate (FDR) in microarray analysis, an FDR-based sample size calculation is essential.
METHOD: We describe an approach to explicitly connect the sample size to the FDR and the number of differentially expressed genes to be detected. The method fits parametric models for degree of differential expression using the Expectation-Maximization algorithm.
RESULTS: The applicability of the method is illustrated with simulations and studies of a lung microarray dataset. We propose to use a small training set or published data from relevant biological settings to calculate the sample size of an experiment. AVAILABILITY: Code to implement the method in the statistical package R is available from the authors.

Entities:  

Mesh:

Year:  2005        PMID: 15932903     DOI: 10.1093/bioinformatics/bti519

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  18 in total

Review 1.  A review of statistical methods for expression quantitative trait loci mapping.

Authors:  Christina Kendziorski; Ping Wang
Journal:  Mamm Genome       Date:  2006-06-12       Impact factor: 2.957

Review 2.  Laser capture sampling and analytical issues in proteomics.

Authors:  Howard B Gutstein; Jeffrey S Morris
Journal:  Expert Rev Proteomics       Date:  2007-10       Impact factor: 3.940

3.  A Bayesian mixture model for metaanalysis of microarray studies.

Authors:  Erin M Conlon
Journal:  Funct Integr Genomics       Date:  2007-09-19       Impact factor: 3.410

4.  Practical guidelines for assessing power and false discovery rate for a fixed sample size in microarray experiments.

Authors:  Tiejun Tong; Hongyu Zhao
Journal:  Stat Med       Date:  2008-05-20       Impact factor: 2.373

5.  Biomarkers of response to Akt inhibitor MK-2206 in breast cancer.

Authors:  Takafumi Sangai; Argun Akcakanat; Huiqin Chen; Emily Tarco; Yun Wu; Kim-Anh Do; Todd W Miller; Carlos L Arteaga; Gordon B Mills; Ana Maria Gonzalez-Angulo; Funda Meric-Bernstam
Journal:  Clin Cancer Res       Date:  2012-08-29       Impact factor: 12.531

6.  Role of SP transcription factors in hormone-dependent modulation of genes in MCF-7 breast cancer cells: microarray and RNA interference studies.

Authors:  Fei Wu; Ivan Ivanov; Rui Xu; Stephen Safe
Journal:  J Mol Endocrinol       Date:  2008-10-24       Impact factor: 5.098

Review 7.  Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients.

Authors:  G Zaza; S Granata; F Sallustio; G Grandaliano; F P Schena
Journal:  Clin Exp Immunol       Date:  2009-11-24       Impact factor: 4.330

Review 8.  Microproteomics: analysis of protein diversity in small samples.

Authors:  Howard B Gutstein; Jeffrey S Morris; Suresh P Annangudi; Jonathan V Sweedler
Journal:  Mass Spectrom Rev       Date:  2008 Jul-Aug       Impact factor: 10.946

9.  Sample size calculation for differential expression analysis of RNA-seq data under Poisson distribution.

Authors:  Chung-I Li; Pei-Fang Su; Yan Guo; Yu Shyr
Journal:  Int J Comput Biol Drug Des       Date:  2013-09-30

10.  A simulation-approximation approach to sample size planning for high-dimensional classification studies.

Authors:  Perry de Valpine; Hans-Marcus Bitter; Michael P S Brown; Jonathan Heller
Journal:  Biostatistics       Date:  2009-02-21       Impact factor: 5.899

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.